Immediate Impact

5 by Nobel laureates 5 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2025 Standout
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
3 intermediate papers

Works of Tetsuya Okayama being referenced

The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines
2017
Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer
2015

Author Peers

Author Last Decade Papers Cites
Tetsuya Okayama 706 413 527 424 77 1.7k
Myra L. Patchen 378 190 478 387 77 2.1k
Muhan Lü 464 425 782 553 108 2.0k
Doerthe Kuester 368 831 643 324 83 2.2k
Changhua Zhang 497 296 632 215 88 1.6k
Shuji Nakano 636 295 595 152 87 1.8k
Dian-Chun Fang 288 572 800 210 99 1.7k
Jatin Roper 553 389 922 215 53 2.1k
Yan Zhang 266 289 374 183 66 1.4k
Jingnan Li 415 250 821 176 91 1.6k
Ryoji Fukushima 589 668 310 236 58 1.9k

All Works

Loading papers...

Rankless by CCL
2026